Press Releases
- AntriaBio Announces Closing of Bridge Financing
- AntriaBio Granted European Patent Allowance for Method of Preparing Site-Specific Protein Conjugates
- AntriaBio Initiates Effort to Raise up to $12 Million in a Private Placement
- AntriaBio Appoints Two Industry Leaders to Its Management Team
- AntriaBio Announces Stock Ticker Symbol Change to ANTB
- UPDATE: AntriaBio Completes Merger and Elects Board of Directors
- AntriaBio Acquires Assets of PR Pharmaceuticals and Announces Intent to Merge With a Public Company
